State of the art in magnetic resonance imaging of hepatocellular carcinoma

Radiol Oncol. 2018 Nov 26;52(4):353-364. doi: 10.2478/raon-2018-0044.

Abstract

Background Liver cancer is the sixth most common cancer worldwide and the second leading cause of cancer mortality. Chronic liver disease caused by viral infection, alcohol abuse, or other factors can lead to cirrhosis. Cirrhosis is the most important clinical risk factor for hepatocellular carcinoma (HCC) whereby the normal hepatic architecture is replaced by fibrous septa and a spectrum of nodules ranging from benign regenerative nodules to HCC, each one of them with different imaging features. Conclusions Furthermore, advanced techniques including the quantification of hepatic and intralesional fat and iron, magnetic resonance elastography, radiomics, radiogenomics, and positron emission tomography (PET)-MRI are highly promising for the extraction of new imaging biomarkers that reflect the tumor microenvironment and, in the future, may add decision-making value in the management of patients with HCC.

Keywords: cirrhosis; hepatic nodule; hepatocellular carcinoma; liver; magnetic; resonance imaging.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Carcinoma, Hepatocellular / diagnostic imaging*
  • Carcinoma, Hepatocellular / epidemiology
  • Carcinoma, Hepatocellular / pathology
  • Contrast Media
  • Humans
  • Liver Neoplasms / diagnostic imaging*
  • Liver Neoplasms / epidemiology
  • Liver Neoplasms / pathology
  • Magnetic Resonance Imaging / methods*

Substances

  • Contrast Media